Research Topics
Genomes and GenesSpecies | Siegfried KasperSummaryCountry: Austria Publications
| Collaborators
|
Detail Information
Publications
Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophreniaSiegfried Kasper
Department of General Psychiatry, University of Vienna, Vienna, Austria
Int J Neuropsychopharmacol 6:325-37. 2003..001). In summary, aripiprazole demonstrated efficacy equivalent or superior to haloperidol with associated benefits for safety and tolerability. Aripiprazole represents a promising new option for the long-term treatment of schizophrenia...
Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regionsRupert Lanzenberger
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Int J Neuropsychopharmacol 13:1129-43. 2010..Dysregulation of the cortisol level might increase the vulnerability for mood disorders by altering limbic 5-HT1A receptors...
Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT studyNikolas Klein
Department of General Psychiatry, Medical University of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
Psychopharmacology (Berl) 191:333-9. 2007..In the present study, the occupancies of SERT after multiple doses of escitalopram and citalopram were compared using the radioligand [(123)I]ADAM and single photon emission computed tomography (SPECT)...
Interaction between serotonin 5-HT2A receptor gene and dopamine transporter (DAT1) gene polymorphisms influences personality trait of persistence in Austrian CaucasiansAlexandra Schosser
Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University Vienna, Vienna, Austria
World J Biol Psychiatry 11:417-24. 2010..004; homo-/heterozygous gene variants: P=0.0004). We conclude that an interaction between DAT1 and 5HT2A genes might influence the temperamental personality trait persistence...
Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopramSiegfried Kasper
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Int Clin Psychopharmacol 24:119-25. 2009....
Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over studyChristian Windischberger
MR Center of Excellence, Center for Biomedical Engineering and Physics, Medical University of Vienna, Vienna, Austria
Neuroimage 49:1161-70. 2010..We believe that reduced reactivity in the medial frontal gyrus found for escitalopram compared to citalopram administration might explain the response differences between study drugs as demonstrated in previous clinical trials...
Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorderAndreas Hahn
Department of Psychiatry and Psychotherapy, Division of Biological Psychiatry, Medical University of Vienna, Vienna, Austria
Neuroimage 56:881-9. 2011....
The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635Patrycja Stein
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Eur J Nucl Med Mol Imaging 35:2159-68. 2008..The present positron emission tomography (PET) study investigated the influence of sex on the major inhibitory serotonergic receptor subtype, the serotonin-1A (5-HT(1A)) receptor...
Seasonality of birth in seasonal affective disorderEdda Pjrek
Department of General Psychiatry, Medical University of Vienna, Austria
J Clin Psychiatry 65:1389-93. 2004..The aim of this investigation was to examine seasonal differences in the frequency of birth in a clinical sample of patients with seasonal affective disorder (SAD)...
Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysisEdda Pjrek
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
J Psychiatr Res 43:792-7. 2009..Reboxetine displayed a faster onset of action, but was associated with more pronounced side effects. Further studies comparing SSRI and NARI in SAD are warranted...
Striatal D(2) receptor occupancy in bipolar patients treated with olanzapineTrawat Attarbaschi
Department of General Psychiatry, Medical University Vienna, Vienna, Austria
Eur Neuropsychopharmacol 17:102-7. 2007..Although we did not find an increased vulnerability for acute EPS in bipolar patients receiving olanzapine at clinical relevant doses, this needs to be replicated with larger sample sizes...
A Cys 23-Ser 23 substitution in the 5-HT(2C) receptor gene influences body weight regulation in females with seasonal affective disorder: an Austrian-Canadian collaborative studyNicole Praschak-Rieder
Department of General Psychiatry, Medical University of Vienna, Austria
J Psychiatr Res 39:561-7. 2005....
Enhanced serotonin transporter function during depression in seasonal affective disorderMatthaus Willeit
Department of Biological Psychiatry, Medical University of Vienna, Vienna, Austria
Neuropsychopharmacology 33:1503-13. 2008..5-HTTLPR was not associated with any of the 5-HTT parameters. In sum, we conclude that the 5-HTT is in a hyperfunctional state during depression in SAD and normalizes after light therapy and in natural summer remission...
Serotonin transporter promoter gene polymorphic region (5-HTTLPR) and personality in female patients with seasonal affective disorder and in healthy controlsNikolaus Thierry
Department of General Psychiatry, Waehringer Guertel 18 20, University of Vienna, A 1090 Vienna, Austria
Eur Neuropsychopharmacol 14:53-8. 2004..The s allele was associated with lower Self-Directedness scores in SAD patients, whereas there were no significant differences in TCI dimensions between patients and controls in carriers of the long allele...
Actigraphy in patients with seasonal affective disorder and healthy control subjects treated with light therapyDietmar Winkler
Department of General Psychiatry, Medical University of Vienna, Vienna, Austria
Biol Psychiatry 58:331-6. 2005..The purpose of this study was to investigate if bright light therapy (BLT) is able to reverse these disturbances...
Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trialsSiegfried Kasper
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Wien Med Wochenschr 160:547-56. 2010..4 ± 7.1 and 12.0 ± 7.2 points at week 6 and by between 11.8 ± 7.7 and 16.0 ± 8.3 points at week 10. In GAD silexan and lorazepam showed comparable HAMA total score reductions (90% CI for mean value difference: -2.3; 2.8 points)...
Typical neuroleptics vs. atypical antipsychotics in the treatment of acute mania in a natural settingMartin Letmaier
Department of General Psychiatry, Medical University of Vienna, Austria
Int J Neuropsychopharmacol 9:529-37. 2006....
Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteersJulia Sacher
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Neuropsychopharmacology 33:1633-41. 2008..Our finding is suggestive that not all atypical antipsychotics cause acute direct effects on glucose disposal and that accurate determination of side effect profile should be performed when choosing an atypical antipsychotic...
Bright-light therapy in the treatment of mood disordersGerald Pail
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Neuropsychobiology 64:152-62. 2011..In the third part, the mode of action, application, efficacy, tolerability and safety of BLT in SAD and other mood disorders are explored...
Escitalopram in a working population: results from an observational study of 2378 outpatients in AustriaDietmar Winkler
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Hum Psychopharmacol 22:245-51. 2007..The aim of this observational study was to evaluate the effectiveness of escitalopram in a naturalistic sample of employed people with mood and anxiety disorders...
Additional support for linkage of schizophrenia and bipolar disorder to chromosome 3q29Alexandra Schosser
Department of General Psychiatry, University Hospital for Psychiatry, Medical University Vienna, Austria
Eur Neuropsychopharmacol 17:501-5. 2007..1r3. A NPL score Z(all) of 3.891 (p=0.000156) was observed with SNP rs225. In short, we found significant linkage scores most telomeric on chromosome 3q29, spanning 3.46 Mbp (7 SNPs)...
Agomelatine in the treatment of seasonal affective disorderEdda Pjrek
Department of General Psychiatry, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090, Vienna, Austria
Psychopharmacology (Berl) 190:575-9. 2007..Previous studies showed that agomelatine is able to restore disrupted circadian rhythms, which were implicated in the pathophysiology of seasonal affective disorder (SAD)...
Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophreniaSiegfried Kasper
Medical University of Vienna, Department of General Psychiatry, Vienna, Austria
Depress Anxiety 20:44-7. 2004..13 (-1.23, -1.04) and after 156 weeks, it was -1.33 (-1.78, -0.87). Therefore, the efficacy of quetiapine for the treatment of anxiety and depressive symptoms is maintained in long-term treatment...
Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorderDietmar Winkler
Department of General Psychiatry, University Hospital for Psychiatry, Wahringer Gurtel 18 20, A 1090, Vienna, Austria
Eur Neuropsychopharmacol 13:129-34. 2003..Due to methodological limitations our results need to be replicated in controlled double-blind randomized clinical trials...
Anger attacks in seasonal affective disorderDietmar Winkler
Department of General Psychiatry, Medical University of Vienna, Austria
Int J Neuropsychopharmacol 9:215-9. 2006..021) and obtained lower global seasonality scores than SAD patients without anger attacks (p=0.001). Anger attacks are experienced as particularly intense in SAD patients and seem to contribute considerably to their symptomatology...
Bright light therapy in seasonal affective disorder--does it suffice?Edda Pjrek
Department of General Psychiatry, University Hospital for Psychiatry, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
Eur Neuropsychopharmacol 14:347-51. 2004..Opposed to treatment guidelines, patients with several depressive episodes did not receive antidepressant maintenance medication or mood stabilizers more often than patients with only a few episodes...
Validation of a simplified definition of anger attacksDietmar Winkler
Department of General Psychiatry, Medical University of Vienna, Vienna, Austria
Psychother Psychosom 75:103-6. 2006..Assessment normally requires the use of specific instruments. The aim of this study was the validation of a simplified definition for anger attacks...
Escitalopram in the long-term treatment of major depressive disorder in elderly patientsSiegfried Kasper
Medical University of Vienna, Vienna, Austria
Neuropsychobiology 54:152-9. 2006..The secondary aim was to examine response to treatment, as measured by change in the Montgomery-Asberg Depression Rating Scale (MADRS) total score from study entry to each visit, using observed cases...
Effect of intravenous magnesium sulphate in reducing irritability and restlessness in pure and polysubstance opiate detoxificationAngela Naderi-Heiden
Department of General Psychiatry, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Psychiatry Res 135:53-63. 2005..Despite promising pilot studies, the administration of Mg did not enable a dose reduction of tranquilizing medication (chlormethiazole) in pure and polysubstance opiate detoxification...
Reduced serotonin-1A receptor binding in social anxiety disorderRupert R Lanzenberger
Department of General Psychiatry, Medical University of Vienna, Vienna, Austria
Biol Psychiatry 61:1081-9. 2007..The objective of this study was to investigate 5-HT1A receptor binding potential (BP) in social anxiety disorder (SAD)...
Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of actionSiegfried Kasper
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
World J Biol Psychiatry 10:117-26. 2009..Collectively, its efficacy, together with its excellent tolerability, makes agomelatine an especially promising antidepressant for the near future...
Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depressionSiegfried Kasper
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Int Clin Psychopharmacol 25:204-13. 2010..In conclusion, WS 5570 exhibits substantially lower incidence rates of adverse events than paroxetine and other SSRIs...
No association of the neuropeptide Y (Leu7Pro) and ghrelin gene (Arg51Gln, Leu72Met, Gln90Leu) single nucleotide polymorphisms with eating disordersJochen Kindler
Department of Psychiatry and Psychotherapy, Division of Biological Psychiatry, Medical University Vienna, Vienna, Austria
Nord J Psychiatry 65:203-7. 2011..Genetic factors likely contribute to the biological vulnerability of eating disorders...
Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjectsA Veronica Witte
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Hum Brain Mapp 30:2558-70. 2009..The present study aimed to elucidate potential interactions between human aggression, the inhibitory serotonergic 5-HT(1A) receptor, and sex hormones...
Sex-specific predictors of criminal recidivism in a representative sample of incarcerated youthBelinda Plattner
Universitätsklinik für Psychiatrie des Kindes und Jugendalters, Medizinische Universität Wien, Vienna, Austria
Compr Psychiatry 50:400-7. 2009..The objective of the study was to identify sex-specific psychopathologic predictors of criminal recidivism among a representative sample of incarcerated youths...
Actigraphic measurements in opioid detoxification with methadone or buprenorphineEdda Pjrek
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
J Clin Psychopharmacol 32:75-82. 2012..Opioid tapering with methadone or buprenorphine leads to characteristic changes of the rest-activity cycle, but further study is required to validate these results...
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trialSiegfried Kasper
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Int Clin Psychopharmacol 25:277-87. 2010..Lavandula oil preparation silexan is both efficacious and safe for the relief of anxiety disorder not otherwise specified. It has a clinically meaningful anxiolytic effect and alleviates anxiety related disturbed sleep...
Anger attacks in depression--evidence for a male depressive syndromeDietmar Winkler
Department of General Psychiatry, Medical University of Vienna, Vienna, Austria
Psychother Psychosom 74:303-7. 2005..It has been proposed that aggression and especially anger attacks play an important role in the symptomatology of depression. Furthermore, it has been hypothesized that these symptoms are more prevalent in males than in females...
Onset of action of escitalopram compared with other antidepressants: results of a pooled analysisSiegfried Kasper
Department of General Psychiatry, Medical University of Vienna, Austria
Int Clin Psychopharmacol 21:105-10. 2006....
Psychosocial background in incarcerated adolescents from Austria, Turkey and former YugoslaviaSusanne Monika Bauer
Department of Psychiatry and Psychotherapy, Medical University of Vienna MUW, Vienna, Austria
Psychiatry Res 185:193-9. 2011..Family systems, even if substantially dysfunctional, seem to be perceived as more stable by migrant youth than by Austrian youth...
Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjectsA Veronica Witte
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Hum Brain Mapp 31:339. 2010..The article to which this erratum refers was published in Hum Brain Mapp 2008, DOI: . (c) 2009 Wiley-Liss, Inc...
Guided self-help versus cognitive-behavioral group therapy in the treatment of bulimia nervosaUrsula Bailer
Department of General Psychiatry, University Hospital of Psychiatry, Medical University of Vienna, Vienna, Austria
Int J Eat Disord 35:522-37. 2004..The aim of the current study was to evaluate whether guided self-help was effective in the short and long term in the treatment of bulimia nervosa...
Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacologySiegfried Kasper
Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
World J Biol Psychiatry 3:133-46. 2002..Our data provide insight into the pathophysiology of neuropsychiatric disorders and may guide future psychopharmacological drug developments...
Gender differences in the psychopathology of depressed inpatientsDietmar Winkler
Department of General Psychiatry, University Hospital for Psychiatry, Wahringer Gurtel 18 20, 1090 Vienna, Austria
Eur Arch Psychiatry Clin Neurosci 254:209-14. 2004..These differences may influence diagnostic practice and gender specific treatment of depression...
A highly parallelized framework for computationally intensive MR data analysisRoland N Boubela
Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
MAGMA 25:313-20. 2012..The goal of this study was to develop a comprehensive magnetic resonance (MR) data analysis framework for handling very large datasets with user-friendly tools for parallelization and to provide an example implementation...
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disordersMartin Aigner
Department of Psychiatry and Psychotherapy, Medical University Vienna MUW, Vienna, Austria
World J Biol Psychiatry 12:400-43. 2011..In this review recommendations for the pharmacological treatment of eating disorders (anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED)) are presented, based on the available literature...
Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trialSiegfried Kasper
Department of General Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Int Clin Psychopharmacol 24:87-96. 2009..1%) and PBO (7.8%), but higher for VXR (20.0%; P < 0.05). In conclusion, PGB was a safe and effective treatment of GAD, with a significantly earlier onset of anxiolytic activity than VXR...
Polymorphisms of the 5-HT2A receptor gene and clinical response to olanzapine in paranoid schizophreniaLuiza Olajossy-Hilkesberger
Division of Biological Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Neuropsychobiology 64:202-10. 2011..The aim of the study was to investigate whether the 5-HT2A receptor gene's polymorphisms (His452Tyr and T102C) have an influence on the response to olanzapine in patients with schizophrenia...
Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depressionSiegfried Kasper
Department of General Psychiatry, Medical University of Wien, MUV, Austria
Eur Neuropsychopharmacol 20:747-65. 2010..In this review, WS 5572, LI 160, WS 5570 and ZE 117 Hypericum extracts have been shown to be significantly more effective than placebo with at least similar efficacy and better tolerability compared to standard antidepressant drugs...
Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorderSiegfried Kasper
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
World J Biol Psychiatry 11:36-44. 2010..To examine suicidal behaviour risk in the short-term placebo-controlled studies of mirtazapine in Major Depressive Disorder (MDD)...
Possible linkage of schizophrenia and bipolar affective disorder to chromosome 3q29; a follow-upAlexandra Schosser
Department of General Psychiatry, University Hospital for Psychiatry, A 1090 Vienna, Austria
J Psychiatr Res 38:357-64. 2004..The results of our follow-up study support our previous linkage finding of schizophrenia and bipolar affective disorder to chromosome 3q29...
The European post-marketing observational sertindole study: an investigation of the safety of antipsychotic drug treatmentSiegfried Kasper
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Wahringer Gurtel 18 20, 1090, Vienna, Austria
Eur Arch Psychiatry Clin Neurosci 260:59-68. 2010..Although CIs remained large, this post-marketing study does not provide any evidence against the use of sertindole under normal conditions. Sertindole was well tolerated and posed no significant safety problems...
White matter hyperintensities and chronicity of depressionAngela Heiden
Department of General Psychiatry, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
J Psychiatr Res 39:285-93. 2005..A prospective study was undertaken to investigate the association between extent of WMHs and clinical outcome in elderly depressed patients...
Atypical antipsychotics in mood disordersSiegfried Kasper
Department of General Psychiatry, University of Vienna, Vienna, Austria
Int Clin Psychopharmacol 17:S1-10. 2002....
Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophreniaSiegfried Kasper
Department of General Psychiatry, Medical University Vienna, Vienna, Austria
Int Clin Psychopharmacol 19:281-9. 2004..In conclusion, quetiapine may be a suitable therapy in the long-term treatment of schizophrenia...
Therapy of treatment resistant depression: focus on the management of TRD with atypical antipsychoticsNikolas Klein
Department of General Psychiatry, Medical University of Vienna, A 1090 Vienna, Austria
CNS Spectr 9:823-32. 2004..This review especially focuses on the augmentation of the antidepressant therapy with atypical antipsychotics...
Recurrent brief depression revisitedLukas Pezawas
Department of General Psychiatry, Medical University of Vienna, Vienna, Austria
Int Rev Psychiatry 17:63-70. 2005..Obviously future treatment studies without the limitations of previous studies are clearly required for RBD. Results of ongoing studies will soon provide the first data on the biological underpinnings of RBD...
Escitalopram in the treatment of depressed elderly patientsSiegfried Kasper
Dept of General Psychiatry, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090, Vienna, Austria
Am J Geriatr Psychiatry 13:884-91. 2005..The authors examined the efficacy and tolerability of escitalopram and fluoxetine versus placebo in the treatment of elderly patients with major depressive disorder (MDD)...
C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorderMatthaus Willeit
Department of General Psychiatry, University Hospital of Psychiatry, Vienna, Austria
Biol Psychiatry 54:682-6. 2003....
Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]Siegfried Kasper
Department of General Psychiatry, Vienna Medical University, Wahringer Gurtel 18 20, A 1090 Wien, Austria
BMC Med 4:14. 2006..The aim of the current study was to assess the antidepressant efficacy and safety of Hypericum perforatum (St. John's wort) extract WS 5570 at doses of 600 mg/day in a single dose and 1200 mg/day in two doses...
Relationship between power spectra of the awake EEG and psychomotor activity patterns measured by short-term actigraphyDietmar Winkler
Department of General Psychiatry, University Hospital for Psychiatry, Vienna, Austria
Neuropsychobiology 48:176-81. 2003..Our results, while preliminary, suggest that short-term actigraphy may be apt to reflect central nervous system arousal...
European College of Neuropsychopharmacology - 16th Congress. 20-24 September 2003, Prague, Czech RepublicDietmar Winkler
University Hospital for Psychiatry, Vienna, Austria
IDrugs 6:1020-3. 2003
Dopaminergic deficit and the role of amisulpride in the treatment of schizophreniaSiegfried Kasper
Department of General Psychiatry, University of Vienna, Vienna, Austria
Int Clin Psychopharmacol 17:S19-26. 2002....
Tardive Dyskinesia: analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin AmericaSiegfried Kasper
Department of General Psychiatry, Medical University of Vienna, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
Schizophr Res 81:139-43. 2006..This study provides new data in a non-Western population with a unique regional geography comparison...
A longitudinal view of triggers and thresholds of suicidal behavior in depressionLukas Pezawas
Department of General Psychiatry, University of Vienna, Austria
J Clin Psychiatry 63:866-73. 2002..RBD and MDD diagnoses were based on DSM-IV criteria. Furthermore, the goal of this study was to determine if impulsivity as an underlying factor could explain high suicide attempt rates in CD...
Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage studySiegfried Kasper
Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
Br J Psychiatry 186:222-6. 2005..Selective serotonin reuptake inhibitors are effective in the treatment of social anxiety disorder and are currently regarded as the pharmacotherapy of choice...
Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidolJohannes Tauscher
Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
Psychopharmacology (Berl) 162:42-9. 2002..Extrapyramidal symptoms (EPS) are common with conventional antipsychotics. Clozapine and other novel antipsychotic substances with lower in vitro affinity for dopamine-2 (D(2)) receptors have a lower propensity to induce EPS...
Quetiapine in the treatment of borderline personality disorderEva Hilger
Department of General Psychiatry, University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
World J Biol Psychiatry 4:42-4. 2003..Thus, there is a clear need for further controlled studies to evaluate pharmacological treatment options for this disorder...
Genome scan for susceptibility loci for schizophrenia and bipolar disorderUrsula Bailer
Department of General Psychiatry, University Hospital for Psychiatry, Vienna, Austria
Biol Psychiatry 52:40-52. 2002..The possibility of a false positive result has to be taken into account. Our data suggest shared loci for schizophrenia and bipolar affective disorders and are consistent with the continuum model of psychosis...
Issues in the treatment of bipolar disorderSiegfried Kasper
Department of General Psychiatry, University Hospital for Psychiatry, Wahringer Gurtel 18 20, 1090 Vienna, Austria
Eur Neuropsychopharmacol 13:S37-42. 2003..Therefore, successful treatment and prevention of bipolar depression remains an essential treatment goal...
Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: results of a multi-centre observational trialDuerten Kudla
Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf, Martinistr 52, 20246 Hamburg, Germany
Eur Psychiatry 22:195-202. 2007..Secondary objectives included quality of life, subjective well-being, tolerability, and safety...
Do we need another atypical antipsychotic?Siegfried Kasper
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Wein, Austria
Eur Neuropsychopharmacol 18:S146-52. 2008..The propensity of sertindole to cause anticholinergic effects, which can be particularly troublesome, is small and, more recently, there have been suggestions that sertindole may have beneficial effects on cognition...
Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptomsSiegfried Kasper
Department of Psychiatry, Medical University of Vienna, Austria
Eur Neuropsychopharmacol 16:S135-41. 2006....
Treatment challenges in the acute hospital settingSiegfried Kasper
World J Biol Psychiatry 6:210-1. 2005
St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trialHans Peter Volz
Psychiatric Department, University of Jena, Philosophenweg 3, 07740 Jena, Germany
Psychopharmacology (Berl) 164:294-300. 2002..Therefore, the efficacy of the Hypericum extract LI 160 in patients with somatoform disorders should be studied in a double-blind placebo-controlled fashion...
[Transcranial magnetic stimulation (TMS)--from diagnostic procedure to therapy]Sylvia Quiner
Universitätsklinik für Neuropsychiatrie des Kindes und Jugendalters, Wien
Wien Klin Wochenschr 114:181-6. 2002....
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of ManiaHeinz Grunze
Department of Psychiatry, Ludwig Maximilians University, Nussbaumstrasse 7, 80336 Munich, Germany
World J Biol Psychiatry 4:5-13. 2003..Key words: bipolar disorder, mania, acute treatment, evidence-based guidelines, pharmacotherapy, antipsychotics, mood stabiliser, electroconvulsive therapy...
Partial response and nonresponse to antidepressant therapy: current approaches and treatment optionsRobert M A Hirschfeld
Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston 77555 0188, USA
J Clin Psychiatry 63:826-37. 2002..Switching to an agent of a different class is probably optimal for those patients who fail to respond to first-line therapy...
[Electroconvulsive therapy as maintenance therapy and for prevention of recurrence in psychiatric disorders and Parkinson disease]Matthaus Willeit
Klinische Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie Wien, Wien, Osterreich
Wien Klin Wochenschr 115:281-90. 2003..First-line evidence data on incidence, dimensions and outcome of cognitive side effects under maintenance electroconvulsive therapy is still warranted...
A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorderAdam Moscovitch
Canadian Sleep Institute, Unit 300, 295 Midpark Way, South East, Calgary, Alberta, T2X 2A8, Canada
Psychopharmacology (Berl) 171:390-7. 2004..The disorder is commonly responsive to light therapy, but antidepressant drug efficacy has not been definitely established. Serotonin selective re-uptake inhibitors are potentially efficacious treatments for SAD...
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorderGuy M Goodwin
Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, England, UK
J Clin Psychiatry 65:432-41. 2004..Two clinical trials, prospectively designed for combined analysis, compared placebo, lithium, and lamotrigine for treatment of bipolar I disorder in recently depressed or manic patients...
Serum lipid levels in seasonal affective disorderEdda Pjrek
Dept of General Psychiatry, Medical University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
Eur Arch Psychiatry Clin Neurosci 257:197-202. 2007..56 +/- 0.96 mmol/l; p = 0.126). The results of this study support the idea that low cholesterol levels may be of pathogenetic importance in SAD. Further study in larger clinical samples is warranted to clarify our findings...
International Consensus Group on Bipolar I Depression Treatment GuidelinesJoseph R Calabrese
Department of Psychiatry, Case Western Reserve University, Cleveland, OH, USA
J Clin Psychiatry 65:571-9. 2004
Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxineStuart A Montgomery
Imperial College School of Medicine, London, UK
J Clin Psychiatry 67:771-82. 2006..The current study compared the efficacy and safety of pregabalin and venlafaxine in patients diagnosed with moderate to severe GAD...
Addressing the limitations of the CATIE studySiegfried Kasper
World J Biol Psychiatry 7:126-7. 2006
Case report: intestinal atonia as an unusual symptom of malignant catatonia responsive to electroconvulsive therapyRainer Marco Kaufmann
Schizophr Res 84:178-9. 2006
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatmentHeinz Grunze
Department of Psychiatry, Ludwig Maximilians University, Nussbaumstrasse 7, 80336 Munich, Germany
World J Biol Psychiatry 5:120-35. 2004..As these guidelines are intended for clinical use, the scientific evidence was not only graded, but also reviewed by the experts of the task force to ensure practicality...
A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorderRobert M A Hirschfeld
Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch at Galveston, TX 77555 0188, USA
Int J Neuropsychopharmacol 7:507-22. 2004..This review presents a balanced selection of the key studies on carbamazepine and oxcarbazepine in bipolar disorder...
Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635Johannes Tauscher
PET Centre, Toronto, Ontario
Arch Gen Psychiatry 59:514-20. 2002....
Menstrual disturbances a rare side-effect of bright-light therapyEdda Pjrek
Int J Neuropsychopharmacol 7:239-40. 2004
Broadening the treatment indication: is the term antipsychotic still justified?Siegfried Kasper
World J Biol Psychiatry 4:144-5. 2003
World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophreniaRajiv Tandon
University of Florida, Tallahassee, USA
Schizophr Res 100:20-38. 2008....
Season of birth in siblings of patients with seasonal affective disorder. A test of the parental conception habits hypothesisEdda Pjrek
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
Eur Arch Psychiatry Clin Neurosci 257:378-82. 2007..Further research could be conducted in non-seasonal depression as there is still a lack of studies on seasonality of birth in affective disorders...
A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorderGeorge I Papakostas
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, WAC 812 Boston, MA 02114, USA
Eur Neuropsychopharmacol 18:122-7. 2008..These results suggest that the NRI reboxetine and the SSRIs differ with respect to their side-effect profile and overall tolerability but not their efficacy in treating MDD...
Evaluation of the Two-Way Communication Checklist as a clinical intervention. Results of a multinational, randomised controlled trialJim Van Os
Department of Psychiatry and Neuropsychology, European Graduate School of Neuroscience, Maastricht University, The Netherlands
Br J Psychiatry 184:79-83. 2004..Patients and doctors often have divergent views on care needs...
Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatineStuart A Montgomery
Imperial College School of Medicine, University of London, London, UK
Int Clin Psychopharmacol 22:283-91. 2007..06 rising to 4.45 points on the Hamilton Depression Rating Scale. In conclusion, agomelatine is effective in treating severe depression...
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter studyDaniel Souery
Department of Psychiatry, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium
J Clin Psychiatry 68:1062-70. 2007....
Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorderJean Pierre Olie
Sainte Anne Hospital, University Department of Psychiatry, Paris, France
Int J Neuropsychopharmacol 10:661-73. 2007....
Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensionsDan J Stein
MRC Unit on Anxiety Disorders, University of Stellenbosch, Cape Town, South Africa
Depress Anxiety 20:175-81. 2004..A six-factor model of social anxiety symptoms is supported by the distinctive association between these symptom dimensions and different areas of disability, but did not predict differential response to escitalopram...
